These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 32379878)

  • 41. Colorectal cancer patient-derived xenografted tumors maintain characteristic features of the original tumors.
    Cho YB; Hong HK; Choi YL; Oh E; Joo KM; Jin J; Nam DH; Ko YH; Lee WY
    J Surg Res; 2014 Apr; 187(2):502-9. PubMed ID: 24332554
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MISTRG mice support engraftment and assessment of nonhuman primate hematopoietic stem and progenitor cells.
    Radtke S; Chan YY; Sippel TR; Kiem HP; Rongvaux A
    Exp Hematol; 2019 Feb; 70():31-41.e1. PubMed ID: 30590092
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of purified and ex vivo manipulated human hematopoietic progenitor and stem cells in xenograft recipients.
    Bock TA; Ziegler BL; Bühring HJ; Scheding S; Brugger W; Kanz L
    Ann N Y Acad Sci; 1999 Apr; 872():200-7; discussion 207-10. PubMed ID: 10372123
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.
    Navone NM; van Weerden WM; Vessella RL; Williams ED; Wang Y; Isaacs JT; Nguyen HM; Culig Z; van der Pluijm G; Rentsch CA; Marques RB; de Ridder CMA; Bubendorf L; Thalmann GN; Brennen WN; Santer FR; Moser PL; Shepherd P; Efstathiou E; Xue H; Lin D; Buijs J; Bosse T; Collins A; Maitland N; Buzza M; Kouspou M; Achtman A; Taylor RA; Risbridger G; Corey E
    Prostate; 2018 Dec; 78(16):1262-1282. PubMed ID: 30073676
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ebola virus disease in mice with transplanted human hematopoietic stem cells.
    Lüdtke A; Oestereich L; Ruibal P; Wurr S; Pallasch E; Bockholt S; Ip WH; Rieger T; Gómez-Medina S; Stocking C; Rodríguez E; Günther S; Muñoz-Fontela C
    J Virol; 2015 Apr; 89(8):4700-4. PubMed ID: 25673711
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Xenograft as In Vivo Experimental Model.
    Porru M; Pompili L; Caruso C; Leonetti C
    Methods Mol Biol; 2018; 1692():97-105. PubMed ID: 28986890
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Humanized mice as preclinical models for myeloid malignancies.
    Gbyli R; Song Y; Halene S
    Biochem Pharmacol; 2020 Apr; 174():113794. PubMed ID: 31926939
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inability of human induced pluripotent stem cell-hematopoietic derivatives to downregulate microRNAs in vivo reveals a block in xenograft hematopoietic regeneration.
    Risueño RM; Sachlos E; Lee JH; Lee JB; Hong SH; Szabo E; Bhatia M
    Stem Cells; 2012 Feb; 30(2):131-9. PubMed ID: 22131151
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New models for cancer research: human cancer stem cell xenografts.
    Baiocchi M; Biffoni M; Ricci-Vitiani L; Pilozzi E; De Maria R
    Curr Opin Pharmacol; 2010 Aug; 10(4):380-4. PubMed ID: 20561817
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Animal xenograft models for evaluation of gene transfer into human hematopoietic stem cells.
    Dao MA; Tsark E; Nolta JA
    Curr Opin Mol Ther; 1999 Oct; 1(5):553-7. PubMed ID: 11249661
    [TBL] [Abstract][Full Text] [Related]  

  • 51. miR145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6-mediated paracrine effects in head and neck cancer.
    Yu CC; Tsai LL; Wang ML; Yu CH; Lo WL; Chang YC; Chiou GY; Chou MY; Chiou SH
    Cancer Res; 2013 Jun; 73(11):3425-40. PubMed ID: 23548270
    [TBL] [Abstract][Full Text] [Related]  

  • 52.
    Chandra S; Cristofori P; Fonck C; O'Neill CA
    Toxicol Pathol; 2019 Jul; 47(5):656-660. PubMed ID: 31064282
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pathological features of highly invasive glioma stem cells in a mouse xenograft model.
    Sadahiro H; Yoshikawa K; Ideguchi M; Kajiwara K; Ishii A; Ikeda E; Owada Y; Yasumoto Y; Suzuki M
    Brain Tumor Pathol; 2014 Apr; 31(2):77-84. PubMed ID: 23670138
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A simple method for simultaneous detection of Fc receptors and differentiation antigens on normal and neoplastic murine hematopoietic cells.
    Siden E; Siegel M
    J Immunol Methods; 1986 Mar; 87(2):251-5. PubMed ID: 2936827
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New interleukin-15 superagonist (IL-15SA) significantly enhances graft-versus-tumor activity.
    Bailey CP; Budak-Alpdogan T; Sauter CT; Panis MM; Buyukgoz C; Jeng EK; Wong HC; Flomenberg N; Alpdogan O
    Oncotarget; 2017 Jul; 8(27):44366-44378. PubMed ID: 28574833
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Know Thy PDX Model.
    Meehan TF
    Cancer Res; 2019 Sep; 79(17):4324-4325. PubMed ID: 31481418
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Engraftment efficacy of human hematopoietic stem cells transplanted into NOD/SCID mice using two methods: intra-bone marrow transplantation of hematopoietic stem cells and intravenous co-transplantation with mesenchymal stem cells.
    Kim DS; Lee MW; Noh YH; Jang MC; Lee SH; Son MH; Jung HL; Yoo KH; Sung KW; Koo HH
    Acta Haematol; 2014; 131(3):179-82. PubMed ID: 24247560
    [No Abstract]   [Full Text] [Related]  

  • 58. TTI-621 (SIRPαFc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding.
    Petrova PS; Viller NN; Wong M; Pang X; Lin GH; Dodge K; Chai V; Chen H; Lee V; House V; Vigo NT; Jin D; Mutukura T; Charbonneau M; Truong T; Viau S; Johnson LD; Linderoth E; Sievers EL; Maleki Vareki S; Figueredo R; Pampillo M; Koropatnick J; Trudel S; Mbong N; Jin L; Wang JC; Uger RA
    Clin Cancer Res; 2017 Feb; 23(4):1068-1079. PubMed ID: 27856600
    [No Abstract]   [Full Text] [Related]  

  • 59. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Syngeneic hematopoietic stem cell transplantation enhances the antitumor immunity of intratumoral type I interferon gene transfer for sarcoma.
    Udagawa T; Narumi K; Goto N; Aida K; Suzuki K; Ochiya T; Makimoto A; Yoshida T; Chikaraishi T; Aoki K
    Hum Gene Ther; 2012 Feb; 23(2):173-86. PubMed ID: 21958207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.